Wall Street’s Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of market turbulence and uncertainty, many investors turn to dividend-yielding stocks for stability and income. These stocks are often from companies with high free cash flows that reward shareholders with generous dividend payouts.
For Benzinga readers looking for the latest analyst insights on their favorite stocks, the Analyst Stock Ratings page is a valuable resource. Here, traders can explore a comprehensive database of analyst ratings, sorted by accuracy.
Here are the ratings from the most accurate analysts for three high-yielding stocks in the healthcare sector:
1. Royalty Pharma plc (NASDAQ:RPRX)
– Dividend Yield: 3.06%
– B of A Securities analyst Geoff Meacham maintained a Buy rating with a price target of $38 on April 12 (64% accuracy rate).
– JP Morgan analyst Chris Schott retained an Overweight rating with a price target of $42 on Feb. 20 (62% accuracy rate).
– Recent News: Royalty Pharma priced a $1.5 billion offering of senior unsecured notes on June 3.
2. Johnson & Johnson (NYSE:JNJ)
– Dividend Yield: 3.38%
– Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $215 on May 6 (68% accuracy rate).
– Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating with a price target of $167 on April 17 (70% accuracy rate).
– Recent News: Johnson & Johnson will host a conference call for investors on July 17 to review second-quarter results.
3. Medtronic plc (NYSE:MDT)
– Dividend Yield: 3.42%
– Wells Fargo analyst Larry Biegelsen kept an Overweight rating with a price target of $105 on May 24 (71% accuracy rate).
– Truist Securities analyst Richard Newitter maintained a Hold rating with a price target of $88 on May 24 (74% accuracy rate).
– Recent News: Medtronic initiated a recall for some versions of its StealthStation S8 application last week.
For investors interested in finding dividend stocks, Benzinga Pro offers tools to scan, analyze, and capture opportunities in the market.